✦ LIBER ✦

Combined modality treatment for advanced non-small cell lung cancer, completely resected

✍ Scribed by Thomas Lad; Ahmad Sadeghi; David Payne; Lawrence Rubinstein

Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 120 KB
Volume: 13
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(87)91015-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined modality treatment for resected

Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence

✍ Ahmad Sadeghi; David Payne; Lawrence Rubinstein; Thomas Lad 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 1020 KB

Combined modality therapy for locally ad

Combined modality therapy for locally advanced non-small cell lung carcinoma

✍ D. Recine; K. Rowland; S. Reddy; M. S. Lee; P. Bonomi; S. Taylor IV; L. P. Faber 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Multi-modality treatment consisting of cisplatin, VP-16, and 5-fluorouracil chemotherapy given concomitantly with external beam radiation was used to treat 64 patients with locally advanced Stage I11 non-small cell lung carcinoma. This regimen was used in a preoperative fashion for four cycles in pa

Combined modality treatment using BID ra

Combined modality treatment using BID radiation for locally advanced non-small cell lung carcinoma

✍ Michael A. Taylor; Salitha Reddy; Myung-Sook Lee; Philip Bonomi; Samuel G. Taylo 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Biological prognostic factors for early

Biological prognostic factors for early stage completely resected non–small cell lung cancer

✍ Lucio Cagini; Massimo Monacelli; Giammario Giustozzi; Luigi Moggi; Guido Bellezz 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 2 views

Pre-treatment prognostic factors in stag

Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment

✍ Philip Bonomi; Meryl Gale; Kendrith Rowland; Samuel G. Taylor IV; Sandra Purl; S 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 745 KB

Combined modality therapy for stage IIIM

Combined modality therapy for stage IIIMO non-small cell lung cancer. A five-year experience

✍ Patricia J. Madej; Jacob D. Bitran; Harvey M. Golomb; Philip G. Hoffman Jr; Thom 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

Between 1975 and 1980, 101 patients with inoperable Stage IIIMO non-small cell lung carcinoma were entered into combined radiotherapy and chemotherapy trials at Michael Reese Hospital and University of Chicago Hospital. Sixty-four percent of the patients responded. Median survival for all patients w